Behavioral Pharmacology Research Seminar Series

FALL 2012 - SPRING 2013
Unless otherwise noted, the seminars are held on
Wednesdays | 2:30 PM | Asthma and Allergy Center (AAC) at The Johns Hopkins Bayview Medical Center. The seminars are open to everyone and light refreshments are served.

For additional information contact:
Dr. Steven Meredith, 410-550-2693 smeredi4@jhmi.edu
Dr. August Holtyn, 410-550-5370 aholtyn1@jhmi.edu

DATE	SPEAKER	AFFILIATION	TOPIC
Sept 12	Matthew Johnson, Ph.D.	BPRU, Johns Hopkins University	Sexual decision making in stimulant addiction: Mechanisms underlying HIV risk
Oct 3	Suzanne Mitchell, Ph.D.	Oregon Health and Science University	Intertemporal choice: Measures, neural correlates and relationships to cigarette smoking.
10	Lara Ray, Ph.D.	University of California, Los Angeles	Behavioral pharmacology of addiction: A clinical approach
Nov 7	Eric Garland, Ph.D., LCSW	Florida State University	Mindfulness-Oriented Recovery Enhancement: Translating 21st Century Behavioral Science and Neuroscience Into An Integrative Treatment for Addiction, Stress, and Pain
14	Nehal Vadhan, Ph.D.	Columbia University	Acute marijuana effects in prodromal psychosis: a probe into the marijuana-schizophrenia link?
Dec 12	Geetha Subramaniam, M.D.	NIDA	Treatment of opiod use disorders in youth
2013
Jan 9	John Roll, Ph.D.	Washington State University	Applying applied behavioral pharmacology research: Examples from the rural Northwest
Jan 16	Marc Branch, Ph.D.	University of Florida	Why and how significance testing is retarding behavioral and other sciences
Mar 6	Kenzie Preston, Ph.D.	NIDA	Collection of self reports and location in real time: stress, craving and illicit drug use
19 TUESDAY	Joseph Belanoff, M.D.	Corcept Therapeutics	From Concept to Corcept: Developing Novel Therapies to Address the Influence of Aberrant Cortisol Activity in Psychiatric and Metabolic Illnesses
April 3	Edward Boyer, M.D., Ph.D.	University of Massachusetts	Mobile Biosensing and Behavioral Interventions
10	Gary Wand, M.D.	Johns Hopkins University	Genetic and Epigenetic Regulation of the FKBP5 Gene and the HPA Axis
23 TUESDAY	Kenzie Preston, Ph.D.	NIDA	Collection of self reports and location in real time: stress, craving and illicit drug use
May 1	Edward Sellers, MD, PhD, FRCPC, FACP	DL Global Partners Inc.	Academia Meets Drug Development Reality: The Case Study of CYP2A6 Inhibition for Smoking Reduction
15	Richard De La Garza, Ph.D.	Baylor College of Medicine	Varenicline as a Potential Treatment for Methamphetamine, Cocaine and Nicotine Addiction